Skip to Content
 

E-Newsletter

  • Subscribe to our e-Newsletter to receive email updates:

  • Related Articles

    Most Recent

    Archives

    Join Us

    News: Cancer Research

    Acting NCI director Lowy to present HPV research lecture

    Thursday, January 12th, 2017

    Douglas R. Lowy, acting director of the National Cancer Institute, will deliver the Vanderbilt-Ingram Cancer Center George Daniel Brooks Lecture at Vanderbilt University Medical Center on Tuesday, Jan. 24, at 11 a.m. in Light Hall, Room 208. The title of the presentation is “Preventing HPV-associated Cancers: Short-term and Long-term Approaches.” Lowy is chief of the […]

    Study to explore lymphedema self care for cancer survivors

    Thursday, December 15th, 2016

    Vanderbilt University School of Nursing (VUSN) Assistant Professor Jie Deng, Ph.D., R.N., has been awarded a $789,000 research scholar grant by the American Cancer Society to develop and test a self-care program for head and neck cancer survivors diagnosed with secondary lymphedema and fibrosis (LEF). LEF causes swelling and the development of hard tissue in […]

    Ozgener family responds to cancer by supporting research

    Thursday, December 15th, 2016

    Nashville entrepreneur-turned-artist Cano Ozgener and his family have repeatedly faced cancer and its consequences, but rather than feel embattled, they’ve chosen to respond by creating beauty to share with others and by actively supporting the mission of the Vanderbilt-Ingram Cancer Center (VICC). Ozgener and his wife, Esen, established the Esen and Cano Ozgener Research Fund […]

    Protecting the blood-brain barrier

    Wednesday, December 14th, 2016

    Interleukin 2 (IL2) is the first effective immunotherapy approved to treat human cancers. But IL2 also disrupts the blood-brain barrier, causing brain edema due to vascular leak syndrome, which limits its use. How IL2 affects brain cells is not currently known. Now, in a paper published in the Journal of Biological Chemistry, graduate student Lukasz […]

    Single-cell analysis of solid tumors

    Wednesday, December 14th, 2016

    Vanderbilt researchers have pioneered a single-cell technique for solid tumors that have been challenging to characterize because they contain many cell types connected in a matrix. Mass cytometry detects proteins and signaling events in cells using antibodies tagged with metal reporters and a specialized mass spectrometer. Detecting 35 proteins and revealing signals in rare “1 […]

    Study links lifestyle factors to formation of high-risk polyps

    Thursday, December 8th, 2016

    Lifestyle factors like cigarette smoking and red meat consumption are known to be associated with an increased risk of colon polyps that can lead to colorectal cancer. Polyps are small growths on the lining of the colon, and while some polyps are harmless others can progress to cancer. A new study led by Vanderbilt University […]

    Award spurs Jonna’s research on ocular melanoma

    Thursday, December 8th, 2016

    Gowtham Jonna, M.D., senior retina fellow at the Vanderbilt Eye Institute, recently received a VitreoRetinal Surgery Foundation (VRSF) Research Award. Gowtham Jonna, M.D. The purpose of the award is to support young investigators conducting research on macular and retinal disease and to encourage a career devoted to retinal disease and research. Jonna is working on […]

    Targeting the “un-targetable”

    Thursday, December 1st, 2016

    Triple negative breast cancers (TNBC) are so named because they lack common genetic “target” mutations that can be easily treated with specific cancer drugs. However, in a recent study published in Molecular Cancer Therapeutics, Deborah Lannigan, Ph.D., and colleagues investigated a new target involved in TNBC called RSK. They demonstrated that RSK can help cancers […]

    Graduate student’s cancer studies land NCI support

    Thursday, November 17th, 2016

    Kamakoti “Kami” Bhat, a fifth-year graduate student in the lab of David Cortez, Ph.D., professor of Biochemistry in the School of Medicine, has achieved a “first” for Vanderbilt University. She is the first Vanderbilt graduate student to win an “F99/K00” predoctoral-to-postdoctoral fellow transition award from the National Cancer Institute (NCI). The grant program is designed […]

    V Foundation grants bolster cancer initiatives

    Thursday, November 17th, 2016

    Two Vanderbilt-Ingram Cancer Center (VICC) investigators have earned grant awards from The V Foundation for Cancer Research, continuing the foundation’s support for innovative cancer research initiatives at VICC. Raymond Blind, Ph.D., assistant professor of Medicine, Biochemistry and Pharmacology, has received a two-year V Foundation grant to examine how proteins induce cancerous tumors to grow. Blind’s […]

    Next Page »« Previous Page

    E-Newsletter

  • Subscribe to our e-Newsletter to receive email updates:

  • Related Articles

    Most Recent

    Archives

    Join Us